Evidence map›Paper›PMID 26972514›Full record

ArticleEpidemics2016

Tuberculosis in Cape Town: An age-structured transmission model.

Nello Blaser, Cindy Zahnd, Sabine Hermans, Luisa Salazar-Vizcaya, Janne Estill, Carl Morrow, Matthias Egger, Olivia Keiser, Robin Wood

Open access · goldAbstract read
In one paragraph

Article in Epidemics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Enhanced Detection ofFrontiers in veterinary science · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.American journal of respiratory and critical care medicine · 2018
    Article
  15. Article
  16. Epidemiology and outcomes ofBMJ global health · 2018
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Nello BlaserInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Cindy ZahndInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Sabine HermansDesmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development,The Netherlands; Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Luisa Salazar-VizcayaInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Janne EstillInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Carl MorrowDesmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa.
Matthias EggerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Olivia KeiserInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. Electronic address: olivia.keiser@ispm.unibe.ch.
Robin WoodDesmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa; Department of Medicine, University of Cape Town,, South Africa; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.
Institute of Social and Preventive Medicine · CHDesmond Tutu HIV Foundation · ZAUniversity of Bern · CHAmsterdam Institute for Global Health and Development · NLUniversity of Cape Town · ZA

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR01AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI REDDY, KRISHNA P · 2011 to 2024
$6.8M
Novel Methods to Inform HIV/TB Clinical Trial DevelopmentR37AI093269 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALENSKY, ROCHELLE P. · 2015 to 2019
$3.8M
NIAID NIH HHS 5U01-AI069924-05NIAID NIH HHS R01 AI058736NIAID NIH HHS R01AI058736NIAID NIH HHS R01 AI093269NIAID NIH HHS R01AI093269NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

backgroundTuberculosis (TB) is the leading cause of death in South Africa. The burden of disease varies by age, with peaks in TB notification rates in the HIV-negative population at ages 0-5, 20-24, and 45-49 years. There is little variation between age groups in the rates in the HIV-positive population. The drivers of this age pattern remain unknown.

methodsWe developed an age-structured simulation model of Mycobacterium tuberculosis (Mtb) transmission in Cape Town, South Africa. We considered five states of TB progression: susceptible, infected (latent TB), active TB, treated TB, and treatment default. Latently infected individuals could be re-infected; a previous Mtb infection slowed progression to active disease. We further considered three states of HIV progression: HIV negative, HIV positive, on antiretroviral therapy. To parameterize the model, we analysed treatment outcomes from the Cape Town electronic TB register, social mixing patterns from a Cape Town community and used literature estimates for other parameters. To investigate the main drivers behind the age patterns, we conducted sensitivity analyses on all parameters related to the age structure.

resultsThe model replicated the age patterns in HIV-negative TB notification rates of Cape Town in 2009. Simulated TB notification rate in HIV-negative patients was 1000/100,000 person-years (pyrs) in children aged <5 years and decreased to 51/100,000 in children 5-15 years. The peak in early adulthood occurred at 25-29 years (463/100,000 pyrs). After a subsequent decline, simulated TB notification rates gradually increased from the age of 30 years. Sensitivity analyses showed that the dip after the early adult peak was due to the protective effect of latent TB and that retreatment TB was mainly responsible for the rise in TB notification rates from the age of 30 years.

conclusionThe protective effect of a first latent infection on subsequent infections and the faster progression in previously treated patients are the key determinants of the age-structure of TB notification rates in Cape Town.

Indexed as

AdolescentAdultAge DistributionChildChild, PreschoolFemaleHumansIncidenceInfantMaleMiddle AgedModels, TheoreticalSouth AfricaTuberculosisYoung AdultAge DistributionCape TownMathematical modelTuberculosis

Identifiers

PMID26972514
PMCPMC4791535
OpenAlexW2194750876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.